Stock A003220 DAEWON PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Daewon Pharmaceutical Co., Ltd.

Equities

A003220

KR7003220001

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 13/05/2024 BST 		5-day change 1st Jan Change
15,200 KRW +3.47% Intraday chart for Daewon Pharmaceutical Co., Ltd. +1.74% -2.94%
03-14 Daewon Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 SD Biotechnologies Co., Ltd. announced that it has received KRW 65 billion in funding from Koino Co.Ltd., Focus Asset Management Co., Ltd., Daewon Pharmaceutical Co., Ltd. CI

Evolution of the average Target Price on Daewon Pharmaceutical Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

13ac.gwMqzB6BUcymlege3pWnBA-bjYsG0DLz7iLuvBzPpCY.0Tp4g03NI73Xwadrrdf1dUj9xsRUmnuXh3GN2XG8zWfQMmOoK-AzgJ_Rmw~9a40a3db313e73d6fb8e448e206a5ef6

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
15,200 KRW
Average target price
21,000 KRW
Spread / Average Target
+38.16%
High Price Target
22,000 KRW
Spread / Highest target
+44.74%
Low Price Target
20,000 KRW
Spread / Lowest Target
+31.58%

Consensus detail

Consensus revision (last 18 months)

Ratings for Daewon Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. A003220 Stock
  4. Consensus Daewon Pharmaceutical Co., Ltd.